Live feed16:05:02·48mINSIDERFilingvia QuantisnowChief Executive Officer Ceesay Abraham sold $93,061 worth of shares (2,210 units at $42.11) as part of a pre-agreed trading plan, decreasing direct ownership by 0.41% to 537,607 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.RAPP· Rapport Therapeutics Inc.Health CareOriginal source
